Winner Medical Signs PurCotton Sales Agreement With Consumer Products Leader in China

SHENZHEN, China, July 2 /PRNewswire-Asia/ -- Winner Medical Group Inc. (OTC Bulletin Board: WMDG, "Winner Medical"), today announced that it signed an agreement with a leading consumer products company in China to provide PurCotton rolls. Pursuant to the terms of the agreement, among others, Winner Medical will provide PurCotton raw materials, which will be processed into feminine products and then distributed throughout China by the consumer product company.

Including this deal, the PurCotton sales to customers in China, Japan, the United States, and other countries are expected to reach approximately $700,000 per month or approximately 150 tonnes per month. The first two PurCotton manufacturing lines are producing in full capacity, and the third manufacturing line is running smoothly, which is expected to gradually increase to normal production capacity in the near future. The Company is planning to purchase the fourth manufacturing line to meet the growing demand.

Mr. Jianquan Li, Chief Executive Officer, commented, "We are delighted to announce the signing of the contract as it proved the recognition of top-tier clients to the premium quality of our PurCotton products."

"This innovative, technologically-enhanced fabric offers significant advantages to synthetic nonwoven products, including eco-friendly, greater absorbency, and higher tensile strength. Furthermore, our patented advanced automation and design process reduces the average cycle time for production of the finished cloth from raw materials. We consider that this confirms the demand for PurCotton, and we believe PurCotton will give Winner Medical a strong competitive edge in the global marketplace," Mr. Li concluded.

There are signs of market demand recovery from the economic crisis. During the second quarter of fiscal 2009, PurCotton sales of the Company grew steadily. The Company has $1,108,000 in raw material sales in the second quarter of fiscal 2009, an increase of 31.43% compared with last quarter, and the management of the Company is confident about a larger increase in the coming quarters.

About Winner Medical

Winner Medical is a leading manufacturer in the medical dressing industry (medical and wound care products) in China. Headquartered in Shenzhen, the Company has eight wholly-owned manufacturing and distribution facilities, four joint-venture factories and over 5,000 employees. The Company engages in the manufacture, sale, research, and development of medical care products, wound care products, home care products and PurCotton products, a nonwoven fabric made from 100% natural cotton. The products are sold worldwide, with Europe, the U.S. and Japan serving as the top three markets. The Company currently holds 50 patents and patent applications in various products and manufacturing processes and is one of the few Chinese companies licensed with the U.S. Food and Drug Administration (FDA) to ship finished, sterilized products directly to the U.S. market. To learn more about Winner Medical, visit Winner Medical's web site http://www.winnermedical.com .

Forward-Looking Statements

This press release contains certain statements that may include "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact included herein are "forward-looking statements" including statements regarding Winner Medical and its subsidiary companies' business strategy, plans and objective and statements of non-historical information. These forward looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involve known and unknown risks and uncertainties. Although Winner Medical believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Winner Medical's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in Winner Medical's periodic reports that are filed with and available from the Securities and Exchange Commission. All forward-looking statements attributable to Winner Medical or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, Winner Medical does not assume a duty to update these forward-looking statements.